Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2015 Jul 16;290(35):21762–21772. doi: 10.1074/jbc.M115.658054

Sickle Cell Hemoglobin with Mutation at αHis-50 Has Improved Solubility*

Ming F Tam 1, Tsuey Chyi S Tam 1, Virgil Simplaceanu 1, Nancy T Ho 1, Ming Zou 1, Chien Ho 1,1
PMCID: PMC4571898  PMID: 26187468

Background: Deoxy sickle cell hemoglobin (Hb S) tetramers polymerize in solution via lateral and axial contacts among neighbors.

Results: αHis-50 → Gln mutation can, whereas αHis-20 → Gln mutation cannot, improve the solubility of Hb S.

Conclusion: α2His-50 interacts with the βS1 CD corner, whereas α2His-20 has minimal interaction with βS1Glu-22.

Significance: α2His-50 contributes significantly to the polymerization of the Hb S tetramers.

Keywords: hemoglobin, mutant, nuclear magnetic resonance (NMR), oxygen binding, protein stability, Csat, autoxidation, sickle cell

Abstract

The unliganded tetrameric Hb S has axial and lateral contacts with neighbors and can polymerize in solution. Novel recombinants of Hb S with single amino acid substitutions at the putative axial (recombinant Hb (rHb) (βE6V/αH20R) and rHb (βE6V/αH20Q)) or lateral (rHb (βE6V/αH50Q)) or double amino acid substitutions at both the putative axial and lateral (rHb (βE6V/αH20R/αH50Q) and rHb (βE6V/αH20Q/αH50Q)) contact sites were expressed in Escherichia coli and purified for structural and functional studies. The 1H NMR spectra of the CO and deoxy forms of these mutants indicate that substitutions at either αHis-20 or αHis-50 do not change the subunit interfaces or the heme pockets of the proteins. The double mutants show only slight structural alteration in the β-heme pockets. All mutants have similar cooperativity (n50), alkaline Bohr effect, and autoxidation rate as Hb S. The oxygen binding affinity (P50) of the single mutants is comparable with that of Hb S. The double mutants bind oxygen with slightly higher affinity than Hb S under the acidic conditions. In high salt, rHb (βE6V/αH20R) is the only mutant that has a shorter delay time of polymerization and forms polymers more readily than Hb S with a dextran-Csat value of 1.86 ± 0.20 g/dl. Hb S, rHb (βE6V/αH20Q), rHb (βE6V/αH50Q), rHb (βE6V/αH20R/αH50Q), and rHb (βE6V/αH20Q/αH50Q) have dextran-Csat values of 2.95 ± 0.10, 3.04 ± 0.17, 11.78 ± 0.59, 7.11 ± 0.66, and 10.89 ± 0.83 g/dl, respectively. rHb (βE6V/αH20Q/αH50Q) is even more stable than Hb S under elevated temperature (60 °C).

Introduction

Hb S2 is a naturally occurring mutant of human adult hemoglobin (Hb A) that has the normally occurring glutamate at the β6 position of Hb A replaced with a valine (1). Heterozygous individuals carrying both Hb S and Hb A genes are protected against Plasmodium infection (2). However, homozygous individuals carrying only the Hb S genes develop hemolytic anemia (3, 4). The deoxygenated Hb S molecules form long fibers within the red blood cells, making them rigid and distorting them into the shape of a sickle. This leads to the blocking of capillary vessels and the destabilization of the red blood cell membranes and premature destruction of erythrocytes (5).

EM studies proposed that the Hb S fibers contain 14 (6) or 16 (7) individual strands twisted in a ropelike fashion. These strands can be arranged into seven or eight double strands, which are held together by inter-double strand, intra-double strand axial and intra-double strand lateral interactions (8, 9). The crystal structure of deoxy-Hb S has been determined (8, 10) and refined to 2.05 Å (11). In this paper, we adopt the designations of Padlan and Love (10, 12) in denoting the subunits of the tetramers in the double strands. The β-subunits that provide acceptor pockets for the βVal-6 are designated as βS1. The subunits that act as valine donors are assigned as βS2. The α-subunits are named according to the β-subunits with which they form dimers. According to the 2.05 Å structural model of Harrington et al. (11), each double strand is held together by the lateral interactions among βS1-subunits of one strand with the βS2- and α2-subunits of tetramers from the other strand (Fig. 1A). The individual double strand is further stabilized by axial interactions between tetramers translated one unit cell along the vertical axis. The βS1-subunit of the lower tetramer makes contacts with the βS2- and the α2-subunits of the upper tetramer. In addition, α1- and α2-subunit interactions are also present (Fig. 1B). The model gives a static picture of interacting amino acid residues that stabilize the polymer.

FIGURE 1.

FIGURE 1.

Putative amino acid residues that participate in lateral (A) and axial contacts (B) in double strand Hb S polymers. The lateral contacts are drawn according to coordinates in Protein Data Bank entry 2HBS. Residues from α2-, βS1-, and βS2-subunits are colored in cyan, blue, and coral, respectively. The axial contacts are presented as in Ref. 8. The yellow double arrows depict the interacting subunits.

Numerous natural or recombinant Hb S mutants with substitution(s) at the putative contact sites have been selected or generated for studying the mechanism and inhibition of Hb S polymerization. The hydrophobicity and the size of the side chain of the amino acid at βS26 or the βS24 position affects the solubility of the resulting mutants (1315). Solubility can be viewed as the concentration of hemoglobin that remains in solution after completion of polymerization. Mutations at the βS1 acceptor pocket can improve moderately the solubility of Hb S, but the mutants are inherently unstable (1618). Himanen et al. replaced the βLys-95 at the acceptor pocket with Ile and disrupted one of the lateral contact sites (19, 20). The mutant is 2.6 times more soluble than Hb S under deoxy conditions (19). Sivaram et al. (21) removed one of the axial interactions by replacing the αLeu-113 with histidine and improved the Hb S solubility by 1.8 times. Mutants that carry a replacement at one of the axial contact sites and a substitution at the acceptor pocket (αP114R/βT87K and αH20Q/βT87Q) have improved solubility but still less than twice that of Hb S (22, 23).

The αHis-20 and the αHis-50 residues are located on the surface of the Hb S tetramer. The imidazole nitrogen of α2His-20 is putatively in close proximity to the carboxyl side chain of βS1Glu-22 (11). A βE22Q mutant presumably disrupted part of the axial interactions between Hb S tetramers and showed a moderate increase (1.28-fold) in solubility (24). The α2His-50 is postulated in lateral hydrogen-bonding distance from the βS1Asp-79 and the βS1Asn-80 side chains (11). Surprisingly, Hb S mutants with substitutions at this position have not been generated to study its effect on Hb S polymerization.

We report here the structural, functional, and polymerization properties of five recombinant Hb S mutants: rHb (βE6V/αH20R), rHb (βE6V/αH20Q), rHb (βE6V/αH50Q), rHb (βE6V/αH20R/αH50Q), and rHb (βE6V/αH20Q/αH50Q). We provide evidence that the putative axial interaction between αHis-20 and βSGlu-22, as suggested by an x-ray crystallographic study, has minimal contribution in stabilizing the Hb S polymers. The solubility of Hb S can be improved markedly by replacing the αHis-50 with a glutamine. In particular, rHb (βE6V/αH50Q) and rHb (βE6V/αH20Q/αH50Q) are nearly 4 times more soluble than Hb S. Furthermore, rHb (βE6V/αH50Q) is more heat-stable than Hb S. To our knowledge, rHb (βE6V/αH50Q) is the most soluble Hb S mutant reported.

Experimental Procedures

Materials

Blood samples were obtained from the local blood bank (a normal human donor) and the National Institutes of Health (an Hb SS human donor) for the isolation of normal Hb A and Hb S, respectively. Restriction and related enzymes used in molecular biology work were purchased from New England Biolabs. The QuikChange site-directed mutagenesis kit was a product from Stratagene. Chromatographic materials used in hemoglobin purification were obtained from GE Healthcare. Reagent grade chemicals were purchased from Sigma and used without further purification.

Recombinant Protein Expression and Purification

The expression vectors constructed in this study were derived from the pHE230 plasmid (22). The pHE230 plasmid encodes the Escherichia coli methionine aminopeptidase and synthetic human α- and β-globin genes under the control of separate tac promoters. The β-globin gene carries a βGlu-6 to valine substitution for the expression of recombinant Hb S proteins. The pHE230 was used as template in polymerase chain reactions to generate plasmids pHE295 (rHb (βE6V/αH20Q)), pHE2012 (rHb (βE6V/αH20R)), pHE296 (rHb (βE6V/αH50Q)), pHE297 (rHb (βE6V/αH20Q/αH50Q)), and pHE2022 (rHb (βE6V/αH20R/αH50Q)). The mutations on the plasmids were confirmed by DNA sequencing analysis of the entire α- and β-globin cDNAs.

The plasmids were transformed into JM109 cells for protein expression. Cells were grown in DM-4 medium (25) at 30 °C in a 20-liter fermenter (B. Braun Biotech International, model Biostat C). The induction and purification of rHb were carried out as described previously (26). Hb A and Hb S from whole blood were purified according to established methods in our laboratory (27, 28). Briefly, red blood cells were lysed with water and then loaded onto a Sephadex G-25 column equilibrated and eluted with 0.05 m Tris-HCl, pH 7.45, and 0.1 m NaCl. For the Hb S sample, it was further separated from other components by loading onto a Mono S column equilibrated with 10 mm phosphate, pH 6.8, and 0.5 mm EDTA. The column was developed with the 20 mm phosphate, pH 8.3, and 0.5 mm EDTA. Fractions corresponding to Hb S were collected. The Hb samples were then saturated with CO and stored frozen at −80 °C. The molecular weights of the Hb subunits were confirmed by mass spectrometry in an ion trap instrument equipped with an electrospray ionization source. The amount of N-terminal methionine cleavage of the samples was estimated by Edman degradation (26). All rHb samples in this study had the correct molecular weights and less than 5% unprocessed N-terminal methionine.

Oxygen Binding Properties

Oxygen dissociation curves were determined with a Hemox analyzer (TCS Medical Products) according to Shen et al. (26). The oxy-Hb samples at 0.1 mm Hb (in terms of heme) were prepared in 0.1 m sodium phosphate in the presence of catalase and superoxide dismutase to reduce the amount of met-Hb to less than 5% in all samples measured (29). Experiments were conducted at 29 °C as a function of pH. The experimental results were fit to the Adair equation using a nonlinear least-squares procedure. The partial pressure (in mm Hg) at 50% oxygenation (P50) and the Hill coefficient (n50) were determined from each curve. The experimental values had an accuracy of ±10% and S.D. values of ±4% between runs.

Dextran-Csat Assay and Polymerization Kinetic Measurements

Dextran-Csat assays were performed according to Tam et al. (28) for microsample handling. The polymerization progress curves were determined by the temperature-induced method of Adachi and Asakura (30) with modifications. Concentrated oxy-Hb sample (5–50 μl) was added to 3 ml of 1.8 m phosphate buffer, pH 7.4, and the solution was purged with nitrogen for 15 min. Sodium dithionite was then added to a final concentration of 10 mm, and the mixture was transferred to a sealed cuvette. The concentration of deoxy-Hb in the sample was determined by light absorbance at 555 nm and calculated by using a millimolar extinction coefficient (mm−1 cm−1) of 12.5. The cuvette was chilled in ice water, and the temperature was monitored closely with a thermocouple. Once the temperature in the cuvette dropped to 2 °C, it was placed in a Cary 50 UV-visible spectrophotometer (Varian) with a cuvette holder preheated and maintained at 30 °C. Immediately, light absorbance at 700 nm, which reflects the turbidity of the sample, was recorded at 15-s intervals up to 2000 or 4000 s, depending on the polymerization speed of the sample. Routinely, the temperature of the sample increased from 2 to 30 °C in 325 s. The delay time of polyermerization (td) was determined from an A700 versus time plot according to Adachi and Asakura (30).

Autoxidation and Thermal Stability of rHb S Mutants

The autoxidation rate (kox) of the samples was determined as described (31). The concentration of oxy-Hb at each time point was calculated according to the equation, [Oxy-Hb] = 0.2174A560 − 0.0573A577 − 0.1616A630 and expressed as a percentage of the original sample. The logarithm (base 10) of the percent oxy-Hb was plotted against time, and the slope of the plot gives the autoxidation rate. Thermal stability measurements were performed according to the outline of Adachi et al. (16). Briefly, oxygenated samples (50 μl, ∼20 mg/ml) in 0.1 m sodium phosphate, pH 7.0, and 1 mm EDTA were aliquoted in quadruplicates into thin-walled polypropylene tubes and inserted into a GeneAmp PCR system 2700 (Applied Biosystems). The instrument was programmed to run at 60 °C for 10 min and then cooled to 25 °C in 1 min. The precipitates in the samples were removed by centrifugation, and the absorbance of the supernatants at 577 and 700 nm were recorded after appropriate dilution. The readings at 700 nm were treated as background and subtracted from the 577 nm readings. The background readings were less than 1% of the absorbance at 577 nm for the most diluted samples. Samples in triplicates without the heating step were used as controls, and the amount of precipitated proteins was calculated accordingly and expressed as a percentage.

Structural Study with 1H NMR Spectroscopy

Proton NMR spectra of Hb A, Hb S, and its five mutants were obtained at 29 °C on Bruker Avance DRX-300 or DRX-600 spectrometers. Hb samples in carbonmonoxy form were concentrated to ∼5% (3.1 mm in terms of heme) and exchanged into 0.1 m sodium phosphate at pH 7.0 in 95% water and 5% deuterium oxide (D2O). Hb S and rHb mutants carrying a substitution at the αHis-50 position (rHb (βE6V/αH50Q), rHb (βE6V/αH20Q/αH50Q), and rHb (βE6V/αH20R/αH50Q)) were diluted to 2 and 4% solutions, respectively, before converting into the deoxy form for the NMR measurements. A jump-and-return pulse sequence was used to suppress the water signal (32).

Results

Oxygen Binding and Cooperativity Properties of rHbs

The O2 binding properties of Hb A, Hb S, and Hb S recombinant mutants with additional single (rHb (βE6V/αH20Q), rHb (βE6V/αH20R), and rHb (βE6V/αH50Q)) or double (rHb (βE6V/αH20Q/αH50Q) and rHb (βE6V/αH20R/αH50Q)) substitutions are summarized in Table 1. The αHis-20 and the αHis-50 are located on the surface of the tetramer (33). As expected, substitutions at these positions do not significantly change the O2 binding properties of the macromolecules. The O2 binding curves of the Hb S single mutants are essentially indistinguishable from that of Hb A or Hb S, whereas the Hb S double mutants have slightly higher O2 binding affinity at low pH. The P50 values determined for the double mutants at acidic pH are ∼20% lower than those of Hb S. All mutants in this study have Hill coefficients (n50) of 2.5 or higher (Table 1). These results are indicative that these rHbs are cooperative in binding O2.

TABLE 1.

Oxygen binding properties and Bohr effect of Hb S and recombinant mutants

Experiments were conducted in 0.1 m sodium phosphate buffer at 29 °C in the presence of a methemoglobin reductase system (29). Values for the Bohr effect were estimated from the pH range in parentheses. Experiment results have an S.D. of <±4% between runs.

Hemoglobins pH P50 n50 −Δ(log P50)/ΔpH
Hb Aa 5.73 22.22 2.71 0.46 (pH 6.56–8.23)
6.25 22.86 2.78
6.56 22.44 2.82
6.75 17.97 2.82
7.06 14.80 2.78
7.40 9.38 2.82
7.83 5.61 2.69
8.23 3.93 2.62
Hb S 5.75 21.73 2.90 0.48 (pH 6.52–7.99)
6.22 22.84 2.95
6.52 21.16 2.99
7.01 14.08 3.09
7.39 8.51 3.20
7.99 4.34 3.12
rHb (βE6V/αH20Q) 5.82 20.98 2.61 0.45 (pH 6.51–8.23)
6.26 21.91 2.73
6.51 19.38 2.68
7.02 13.13 2.78
7.40 7.79 2.90
7.71 5.49 2.93
8.23 3.34 2.90
rHb (βE6V/αH20R) 5.80 21.61 2.81 0.48 (pH 6.51–8.10)
6.27 22.50 2.88
6.51 21.14 2.98
6.97 13.63 2.85
7.39 8.48 3.06
8.10 3.75 2.99
rHb (βE6V/αH50Q) 6.53 23.74 2.97 0.43 (pH 6.77–8.02)
6.77 20.06 2.87
7.4 11.37 3.19
7.66 7.96 3.15
8.02 8.02 2.85
rHb (βE6V/αH20R/H50Q) 5.74 16.41 2.47 0.45 (pH 6.49–7.98)
6.19 18.40 2.58
6.49 16.41 2.58
7.02 10.99 2.76
7.38 6.93 2.93
7.98 3.63 2.83
8.62 2.81 2.78
rHb (βE6V/αH20Q/H50Q) 5.76 16.85 2.62 0.46 (pH 6.52–8.00)
6.22 18.61 2.68
6.52 17.08 2.68
7.03 11.48 2.78
7.41 7.07 2.81
8.00 3.70 2.69
8.70 2.60 2.57

a Data from Tam et al. (31).

Hemoglobin releases hydrogen ions upon oxygenation, and this alkaline Bohr effect can be expressed mathematically as ΔH+ = −Δlog P50/ΔpH (34). The numbers of protons released per heme for Hb A, Hb S, and the recombinant mutants are listed in Table 1. The rHbs release 0.43–0.48 proton/heme, whereas Hb A and Hb S release 0.46 and 0.48 proton/heme, respectively. Hence, the mutants we generated are effective oxygen carriers.

Dextran-Csat and Polymerization Kinetic Measurements

The solubilities of Hb S and its recombinant mutants in the presence of dextran and low ionic strength buffer were determined according to the microassay of Tam et al. (28) and are listed in Table 2. Harrington et al. (11) estimated that in the double-stranded form of Hb S fibers, the imidazole nitrogen of the α2His-20 is 3.55 Å from the side chain oxygen of βS1Glu-22 and suggested that they could form axial interaction. By eliminating the positive charge from the αHis-20, the rHb (βE6V/αH20Q) mutant has a Csat value of 3.04 ± 0.17 g/dl, which is close to that of Hb S (2.95 ± 0.10 g/dl). By elongating the side chain, the rHb (βE6V/αH20R) mutant apparently has improved interaction with neighboring tetramers, and the Csat value decreased to 1.86 ± 0.20 g/dl. These results imply that the interaction between the αHis-20 and the βGlu-22 of Hb S is minimal under dextran-Csat assay conditions at pH 7.5. In contrast, eradicating the positive charge from the αHis-50 position improves the solubility of the mutated rHb S. The rHb (βE6V/αH50Q) mutant has a Csat value of 11.78 ± 0.59 g/dl, which is 4 times higher than Hb S. This substitution can also improve the solubility of the rHb S mutated at the αHis-20 position. The rHb (βE6V/αH20R/αH50Q) mutant has a Csat value of 7.11 ± 0.66 g/dl, which is 3.8- and 2.4-fold higher than that of the rHb (βE6V/αH20R) mutant and Hb S, respectively. The rHb (βE6V/αH20Q/αH50Q) mutant has a Csat value of 10.89 ± 0.83 g/dl, which is ∼3.6-fold higher than that of the rHb (βE6V/αH20Q) mutant and Hb S. Therefore, the solubility of Hb S can be improved by disrupting the lateral contacts between the α2CD and the βS1EF corners.

TABLE 2.

Dextran-Csat value, autoxidation rate, and thermal stability of Hb S and recombinant mutants

Dextran-Csat Autoxidation rate Thermal stabilitya
g/dl h1
Hb A NDb 0.00086 ± 0.0002 5.8 ± 0.1
Hb S 2.95 ± 0.10 0.0029 ± 0.0002 15.7 ± 0.2
rHb (βE6V/αH20R) 1.86 ± 0.20 2 0.0024 ± 0.0001 14.1 ± 0.2
rHb (βE6V/αH20Q) 3.04 ± 0.17 0.0023 ± 0.0002 13.9 ± 0.4
rHb (βE6V/αH50Q) 11.78 ± 0.59 0.0031 ± 0.0007 20.6 ± 1.0
rHb (βE6V/αH20R/αH50Q) 7.11 ± 0.66 0.0023 ± 0.0001 15.9 ± 0.9
rHb (βE6V/αH20Q/αH50Q) 10.89 ± 0.83 0.0025 ± 0.0002 12.0 ± 0.3

a Percentage denatured proteins after heating at 60 °C for 10 min.

b ND, not determined.

The polymerization kinetics of the rHb S mutants was determined in 1.8 m phosphate buffer, pH 7.4, at 30 °C. The increase in turbidity of the sample, as measured by light scattering at 700 nm, reflects sample polymerization. The A700 values at various time points for each protein concentration can be plotted as a function of time to generate a sigmoidal curve. Some representative results for Hb S and its five mutants are presented in Fig. 2. The intercept of the slope at the x axis gave the delay time of polymerization (td). The delay time between the beginning of the experiment and the onset of polymerization depends on the initial hemoglobin concentration and increases as the protein concentration decreases. The logarithmic plots of the reciprocal of the delay time (td) versus the concentration of proteins are presented in Fig. 3 and summarize the data for multiple mutants at various concentrations for direct comparison. The plots for rHb (βE6V/αH20Q), rHb (βE6V/αH50Q), rHb (βE6V/αH20Q/αH50Q), and rHb (βE6V/αH20R/αH50Q) fall to the right of that representing Hb S. The results indicate that these mutants have longer polymerization delay time than Hb S. The plot for rHb (βE6V/αH20R) is shifted to the left of the plot for Hb S. The result suggests that rHb (βE6V/αH20R) forms polymers faster than Hb S. Among these six plots in Fig. 3, only the line representing rHb (βE6V/αH20R) has a slope (1.91) significantly steeper than others (1.46–1.79). The slope of the line (m) is related to the size of the nucleus in forming aggregates (35, 36). Hence, the nuclei formed in the rHb (βE6V/αH20R) solution are larger than for Hb S and other mutants in this study.

FIGURE 2.

FIGURE 2.

Polymerization of Hb S and its recombinant mutants. Polymer formation was assessed by light scattering at 700 nm in 1.8 m phosphate buffer at pH 7.4. Data are presented for each protein at two different concentrations. The scales on the x and y axis vary among the panels.

FIGURE 3.

FIGURE 3.

Kinetics of polymerization of Hb S and its recombinant mutants in concentrated phosphate buffer. The log values of the reciprocal of the delay times of polymerization are plotted against the log of hemoglobin concentrations. The slopes (m) of the plots are indicated.

Autoxidation and Thermal Stability

It has been suggested that Hb mutants have the potential to be used in gene therapy for sickle cell anemia (22). It is imperative to determinate the autoxidation rate (kox) and stability of the putative candidates. The successful candidate should have kox and stability similar to that of Hb S, if not Hb A. The kox of Hb A, Hb S, and its mutants were determined and are listed in Table 2. Hb S has a kox of 0.0029 ± 0.0002 h−1, which is 3.4 times higher than that of Hb A (0.00086 ± 0.0002 h−1). The Hb S mutants in this study all have substitution(s) on the protein surface and away from the heme pocket (33). Consequently, these mutants have kox ranging from 0.0023 to 0.0031 h−1, very similar to that of Hb S.

Reportedly, oxy-Hb S was found mechanically (18) and thermally (16, 18) less stable than oxy-Hb A. We examined the thermal stability of the oxy form of Hb A, Hb S, and its mutants in a PCR thermal cycler, which has a more precise temperature control than in previous studies. Hb S has 15.7 ± 0.2% of denatured protein after heating at 60 °C for 10 min. Hb A has only 5.8 ± 0.1% denatured protein under the same experimental conditions. The results for the Hb S mutants are listed in Table 2. With the exception of rHb (βE6V/αH50Q), all mutants have thermal stability equal to or better than Hb S. In particular, rHb (βE6V/αH20Q/αH50Q) has only 12.0 ± 0.3% denatured protein under the same treatment, significantly better than Hb S. Apparently, Hb S mutants with substitution(s) on the protein surface are thermally more stable than Hb S with an additional mutation in the acceptor pocket (16, 18).

Structural Properties Investigated with 1H NMR

The possible conformational changes of the rHb S mutants were investigated with 1H NMR. αHis-122 and αHis-103 are located at the α1β1 interface, and the NHϵ1 of their side chains give signals at 12.9 and 12.1 ppm, respectively (3739). The exchangeable proton resonance spectra of the CO form of the samples show clearly that these two amino acid residues have not been disturbed in the five mutants studied (Fig. 4A).

FIGURE 4.

FIGURE 4.

1H NMR spectra of the CO form of Hb A, Hb S, and rHbs. Spectra of exchangeable proton resonances (A) and ring current-shifted proton resonances (B) were acquired at 600 MHz in 95% H2O, 5% D2O, and 0.1 m sodium phosphate buffer at pH 7.0 and 29 °C.

βTrp-37 is located at the α1β2 interface, and its NHϵ1 atom gives a resonance peak at 10.6 ppm (39, 40). As demonstrated in Fig. 4A, the resonances between 9.5 and 11.0 ppm are similar among Hb A, Hb S, and the five recombinant mutants. Therefore, substitutions at αHis-20 and αHis-50 do not change the quaternary structure of the liganded Hb A at the α1β2 interface.

Resonances from 0 to −3 ppm belong to the non-exchangeable ring current-shifted protons, and they provide insight into the tertiary structure of the heme pockets. The γ2-CH3 groups of αVal-62 and βVal-67 of the distal heme pocket give resonances at −1.75 and −1.82 ppm relative to 2,2-dimethyl-2-silapentanesulfonic acid, respectively (41, 42). The signals at −1.75 ppm are similar among all six proteins studied. However, the signal at −1.82 ppm is shifted slightly upfield for the rHb (βE6V/αH20R/αH50Q) and the rHb (βE6V/αH20Q/αH50Q) mutants, although the mutations are on the α-subunit (Fig. 4B). Moreover, the resonances between −0.7 and −1.1 ppm for the double mutants differ significantly from those for the other five proteins. But, we have not yet assigned the resonances for these signals and cannot comment on their importance.

The 1H NMR spectra for the deoxy form of Hb A, Hb S, rHb (βE6V/αH50Q), rHb (βE6V/αH20R/αH50Q), and rHb (βE6V/αH20Q/αH50Q) are presented in Fig. 5. The deoxy forms of Hb S mutants with a single substitution at αHis-20 are at least 3-fold less soluble than mutants carrying a substitution at the αHis-50 position, and they were excluded from the NMR experiments. The hyperfine-shifted proton resonances of the NδH exchangeable proton of αHis-87 and βHis-92 in the proximal heme pocket appear at 63 and 76 ppm from 2,2-dimethyl-2-silapentanesulfonic acid, respectively (43, 44). The signals for the mutants, Hb S, and Hb A appear at the same positions (Fig. 5A).

FIGURE 5.

FIGURE 5.

1H NMR spectra of the deoxy form of Hb A, Hb S, and rHbs. Spectra of the hyperfine-shifted NδH proton resonances of the proximal histidyl residues (A) and the hyperfine-shifted and exchangeable proton resonances (B) were acquired at 300 MHz in 95% H2O, 5% D2O, and 0.1 m sodium phosphate buffer at pH 7.0 and 29 °C.

Fig. 5B presents the spectral region of the deoxy form of the proteins between 11 and 25 ppm downfield from 2,2-dimethyl-2-silapentanesulfonic acid. The porphyrin rings of the α- and β-subunits resonate at 17.0 and 22.6 ppm, respectively (45). The signals at 14.1 and 11.2 ppm have been assigned to the hydrogen bonds between αTyr-42 and βAsp-99 and between βTrp-37 and αAsp-94, respectively. These residues are located in the α1β2 interface, and the resonances are important T-state markers of the deoxy-Hb A (39, 46, 47). We did not detect any difference in chemical shift for these signals among the five proteins. The signals at 12.9 and 12.1 ppm belong to αHis-122 and αHis-103, as in the spectra for the liganded form of the molecules. Again, we cannot detect any shift in the signals for the mutants.

In summary, the β-heme pockets of the liganded form of rHb (βE6V/αH20R/αH50Q) and rHb (βE6V/αH20Q/αH50Q) changed slightly when compared with that of Hb A or Hb S. Besides that, the tertiary and quaternary structures of the four mutants are similar to that of Hb A or Hb S.

Discussion

The oxy forms of Hb A and Hb S have similar solubility. Upon deoxygenation, the solubility of Hb A was decreased by half, whereas that of Hb S diminished by 100 times (48). The primary sequences of Hb S and Hb A differ in a single amino acid. Hb S has a hydrophobic valine instead of a hydrophilic glutamic acid at the β6 position. Furthermore, mutants with isoleucine (49) and lysine (13, 50) at the β6 position have lower and higher solubility, respectively, than Hb S. Therefore, lowering solubility and forming polymers can be attributed to this single amino acid substitution, a direct result of introducing undesirable interactions among surface residues of neighboring tetramers.

We have generated five Hb S mutants for this study. Three of them carry an additional substitution at the α20 or the α50 position (rHb (βE6V/αH20R), rHb (βE6V/αH20Q), and rHb (βE6V/αH50Q)), whereas the other two carry mutations at both α20 and α50 positions (rHb (βE6V/αH20R/αH50Q) and rHb (βE6V/αH20Q/αH50Q)). These Hb S mutants have substituted amino acid(s) on the surface of the tetrameric protein and away from the heme pockets and the α1β1 and the α1β2 interfaces. Hence, these mutants are structurally (Figs. 4 and 5) and functionally (Fig. 2 and Tables 1 and 2) similar to Hb S. Their autoxidation rate is similar to that of Hb S. For some mutants (rHb (βE6V/αH20Q), rHb (βE6V/αH20Q), and rHb (βE6V/αH20Q/αH50Q), they are thermally more stable than Hb S.

EM studies (6, 51) indicate that the double strands within the Hb S fibers have a slight helical twist. The results give an overall conformation of the fiber but cannot pinpoint the interacting residues with certainty. Data from x-ray crystallography have higher resolution, but the double strands found in the Hb S crystals are straight and do not have the helical twist (1012).

Harrington et al. (11) refined the crystal structure of deoxy-Hb S to 2.05 Å and then employed the program CONTACT to identify inter- and intrastrand interacting residues. With this approach, 34 residues from the β12-subunits and 9 residues from the α12-subunits are suggested to be within interacting distances either laterally or axially among Hb S tetramers. These putative interacting residues are listed in Table 3.

TABLE 3.

Putative amino acid residues that participate in lateral and axial contacts in double strand Hb S polymers (11)

Interacting residues are highlighted with the same color or connected with double-headed arrows.

graphic file with name zbc039152519t003.jpg

According to the model of Harrington et al. (11), the axial contacts can be grouped as follows: (i) the GH corner (α1Pro-114 and α1Ala-115) of the α1-subunit of the lower tetramer interacts with the GH corner (α2Glu-116) and A helix (α2Lys-16) of the α2-subunit of the upper tetramer; (ii) the A helix (βS1Gly-16, βS1Lys-17, and βS1Val-18) of the βS1-subunit of the lower tetramer interacts with the G helix (βS2His-116 and βS2His-117) and the GH corner (βS2Phe-118 and βS2Lys-120) of the βS2-subunit of the upper tetramer; (iii) the G helix (βS1His-117) and the GH corner (βS1Phe-118, βS1Gly-119, and βS1Glu-121) of the βS1-subunit of the lower tetramer interacts with the GH corner (α2Pro-114 and α2Ala-115) of the α2-subunit of the upper tetramer; and (iv) the B helix (βS1Glu-22) of the βS1-subunit of the lower tetramer interacts with the B helix (α2His-20) of the α2-subunit of the upper tetramer. These interacting residues are presented as a diagram in Fig. 1B. Because the coordinates in the Protein Data Bank file 2HBS cannot pinpoint the relative positions of the interacting residues, we summarized the interacting residues as did Wishner et al. (8).

The lateral interactions contributing to the Hb S polymerization are mainly between βS1 of one strand and the βS2 of the neighboring strand. Seven residues from the A helix, including the substituted βVal-6, plus two residues from the H helix of βS2 interact with 13 residues from the E and F helices and the EF and FG corners of the neighboring βS1-subunit (Table 3 and Fig. 1A). The interactions between the βS1 EF corner (βAsp-79 and βAsn-80) and the α2 CD corner (αSer-49 and αHis-50) constitute the only lateral contact between βS- and α-subunits. In particular, the side chains of βS1Asp-79 and α2His-50 are reportedly separated by only 2.83 Å (11). However, according to the deposited coordinates (Protein Data Bank code 2HBS) of the two Hb S tetramers in the unit cell, the imidazole nitrogen of α2His-50 is 6 Å from the side chain oxygen of βS1Asp-79. The distance between the side chains of α2His-50 and βS1Asn-80 is shorter (3.86 Å) but still too far for hydrogen bonding. Therefore, these results generated from docking calculations should be confirmed with biochemical and mutagenesis studies.

Careful scrutiny of the docking results reveals that only five (αLys-16, αHis-20, αPro-114, αAla-115, and αGlu-116) and two (αSer-49 and αHis-50) residues on the α-subunits contribute to either axial or lateral interactions, respectively. Russu and Ho (52) have suggested the presence of histidyl residues at contact areas between Hb S molecules in pregelation aggregates. Therefore, αHis-20 and αHis-50, the only two histidines among the list, were selected for mutation, and its effect on Hb S solubility was studied.

Presumably, α2His-20 and βS1Glu-22 form an interacting pair in the Hb S fibers. Nagel et al. (53) compared the β and γ sequences of the hemoglobin subunit and determined the minimum gelling concentration of a mixture of Hb S and Hb G Coushatta (βGlu-22 → Ala). They suggested that βSGlu-22 possibly partially stabilized the deoxy-Hb S polymers. Acharya and Seetharam (54) modified the βSGlu-22 and the βSGlu-43 with glucosamine, and they observed an increase in the solubility of the modified deoxy-Hb S by about 55%. However, the addition of glucosamine not only eliminated the carboxyl side chain of βSGlu-22 but appended also a bulky carbohydrate derivative that might interfere with subunit-subunit interactions. Therefore, whether disrupting the putative α2His-20 and βS1Glu-22 interaction can improve Hb S solubility is debatable.

Hb S carrying mutations at the α20 position have been studied (23, 24, 55). Rhonda et al. (55) measured the solubility of an equal mixture of Hb S and Hb Le Lamentin (Hb S with an αHis-20 → Gln mutation) and claimed a 1.6-fold increase in Csat value. Srinivasulu et al. (23) measured the solubility of Hb Le Lamentin with an oxygen affinity method and reported only a 26% increase in Csat. Banerjee et al. (24) used the dextran-Csat method of Bookchin et al. (56) and reported a 28% increase in Csat value for the same mutant.

We used the dextran-Csat method of Tam et al. (28) developed for microsample handling in this study. Our Hb Le Lamentin (rHb (βE6V/αH20Q)) has a Csat value similar to that of Hb S without any pronounced improvement (Table 2), although the polymers formed more slowly than for Hb S (Fig. 3). The 3.55-Å distance (11) between the Nϵ2 atom of the α2His-20 and the Oϵ2 atom of the β1Glu-22 is possibly too long for optimal hydrogen bond formation. However, the structure of Hb in solution is flexible, and its backbone and side chains can exhibit various types of motions (see Ref. 57 for a review). Hence, it is conceivable that a subpopulation of the Hb possibly assumes a conformation with a shorter distance between α2His-20 and β1Glu-22 for hydrogen bonding. The conservative substitution of Gln for His at the α20 position disrupts this interaction and abolished the contribution of α2His-20 and β1Glu-22 to the polymerization process, resulting in a lengthening in the delay time of polymerization.

To further explore the possible interaction between α2His-20 and βS1Glu-22, we generated the rHb (βE6V/αH20R) mutant. rHb (βE6V/αH20R) has a Csat value of 1.86 ± 0.20 g/dl (Table 2), which is only two-thirds of that of Hb S. It has also a shorter delay time of polymerization, and the size of nucleus in forming aggregates is larger than for Hb S (Fig. 3). Hence, the interactions between neighboring Hb S tetramers are intensified by introducing a longer side chain carrying a positive charge at the α20 position. Adachi et al. (58) have investigated the polymerization of Hb S in the presence of Hb A2 variants carrying Val, Glu, and Thr at positions 6, 22, and 87 of the δ-subunit. They concluded also that it is not necessary to change Glu to Ala at the β22 position in preparing anti-sickling hemoglobin. Therefore, we conclude that the interaction between α2His-20 and βS1Glu-22 contributes minimally to the polymerization of Hb S.

The lateral interactions among residues on the βS2-subunit with the neighboring βS1 EF pocket have been studied extensively. For instance, mutants with an aromatic residue (phenylalanine or tryptophan) at the β6 position are more soluble than Hb S (59). Probably, it is more difficult to insert a bulky side chain into the EF pocket. The observation that the rHb (βE6V/βL88F) mutant, with an aromatic residue in the EF pocket, also has higher solubility substantiates this speculation (16). Other residues on or near the acceptor site have also been mutated to disrupt the lateral interactions in various studies. In general, the mutants have moderately improved solubility (16, 18, 19, 22, 60, 61), but some of them reportedly suffered from thermal instability (16, 18, 61).

According to the model proposed by Harrington et al. (11), βS1Asp-79 interacts with both α2Ser-49 and α2His-50, whereas βS1Asn-80 interacts only with α2His-50. Nagel et al. (53) have investigated the solubility of Hb S in the presence of an Hb A2 mutant containing a βAsn-80 → Lys mutation and observed a 19% increase in solubility. McCune et al. (62) generated an Hb S mutant with the addition of βGlu-22 → Ala and βAsn-80 → Lys substitutions. This mutant is better than Hb A but less effective than Hb F in inhibiting the polymerization of Hb S. Srinivasulu et al. (63) substituted the αSer-49 on Hb S with Arg and observed a 60% increase in solubility. However, the contribution of α2His-50 in stabilizing the Hb S polymer has never been tested.

To address this issue, we generated the rHb (βE6V/αH50Q) mutant, which has a Csat value 4 times higher than that of Hb S (Table 2). The results show clearly that removing the positive charge on αHis-50 interrupts its interaction with the neighboring βS1Asp-79 and/or βS1Asn-80. Furthermore, this substitution at the αHis-50 position also improves the solubility of rHb (βE6V/αH20R) and rHb (βE6V/αH20Q). The resulting rHb (βE6V/αH20Q/αH50Q) mutant has a dextran-Csat value of 10.89 ± 0.80 g/dl, which is 3.7 times higher than Hb S. It has similar autoxidation rate and better thermal stability than Hb S (Table 2). The rHb (βE6V/αH20R/αH50Q) mutant has a dextran-Csat value of 7.11 ± 0.66 g/dl (Table 2), which is 3.8 times better than that of the rHb (βE6V/αH20R) mutant. Both mutants have a longer delay time of polymerization compared with that of Hb S (Fig. 3). Furthermore, the results also suggest that the effects of mutation at positions α20 and α50 are independent of each other.

In summary, the results in this report show that (i) the interaction between α2His-20 and βS1Glu-22 is minimal in stabilizing the Hb S polymer, and (ii) the Hb S polymer can be destabilized by replacing the histidyl residue at the α50 position with a Gln. The resulting protein is functionally and structurally similar to Hb S. The mutant carrying the αHis-50 → Gln substitution can be a candidate for gene therapy of sickle cell disease.

Author Contributions

M. F. T. and C. H. designed the study and wrote the paper. T. C. S. T. purified all of the samples in this study and performed and analyzed the experiments in Table 2. V. S. collected and analyzed all NMR spectra. N. T. C. performed and analyzed the experiments shown in Table 1. M. Z. performed and analyzed the experiments shown in Figs. 2 and 3. All authors reviewed the results and approved the final version of the manuscript.

Acknowledgment

We thank Dr. Chwan-Deng Hsiao (Academia Sinica) for helpful discussion on the crystal structure of Hb S.

*

This work was supported, in whole or in part, by National Institutes of Health Grant R01GM084614. The authors declare that they have no conflicts of interest with the contents of this article.

2
The abbreviations used are:
Hb S
sickle cell hemoglobin, Hb A with βGlu-6 → Val (βE6V) mutation
Hb A
human adult hemoglobin
rHb
recombinant hemoglobin
rHb (βE6V/αH20R)
recombinant sickle cell hemoglobin with additional αHis-20 → Arg mutation
rHb (βE6V/αH20Q)
recombinant sickle cell hemoglobin with additional αHis-20 → Gln mutation
rHb (βE6V/αH50Q)
recombinant sickle cell hemoglobin with additional αHis-50 → Gln mutation
rHb (βE6V/αH20R/αH50Q)
recombinant sickle cell hemoglobin with additional αHis-20 → Arg and αHis-50 → Gln mutations
rHb (βE6V/αH20Q/αH50Q)
recombinant sickle cell hemoglobin with additional αHis-20 → Gln and αHis-50 → Gln mutations
met-Hb
methemoglobin
HbCO
carbonmonoxy hemoglobin
P50
partial O2 pressure at 50% saturation
n50
Hill coefficient at 50% O2 saturation
Csat
solubility
td
delay time of polymerization
kauto
autoxidation rate.

References

  • 1. Ingram V. M. (1959) Abnormal human haemoglobins. III. The chemical difference between normal and sickle cell haemoglobins. Biochim. Biophys. Acta 36, 402–411 [DOI] [PubMed] [Google Scholar]
  • 2. Williams T. N. (2006) Human red blood cell polymorphisms and malaria. Curr. Opin. Microbiol. 9, 388–394 [DOI] [PubMed] [Google Scholar]
  • 3. Eaton W. A., Hofrichter J. (1987) Hemoglobin S gelation and sickle cell disease. Blood 70, 1245–1266 [PubMed] [Google Scholar]
  • 4. Reiter C. D., Wang X., Tanus-Santos J. E., Hogg N., Cannon R. O., 3rd, Schechter A. N., Gladwin M. T. (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 8, 1383–1389 [DOI] [PubMed] [Google Scholar]
  • 5. Bensinger T. A., Gillette P. N. (1974) Hemolysis in sickle cell disease. Arch. Intern. Med. 133, 624–631 [PubMed] [Google Scholar]
  • 6. Dykes G. W., Crepeau R. H., Edelstein S. J. (1979) Three-dimensional reconstruction of the 14-filament fibers of hemoglobin S. J. Mol. Biol. 130, 451–472 [DOI] [PubMed] [Google Scholar]
  • 7. Wellems T. E., Josephs R. (1979) Crystallization of deoxyhemoglobin S by fiber alignment and fusion. J. Mol. Biol. 135, 651–674 [DOI] [PubMed] [Google Scholar]
  • 8. Wishner B. C., Ward K. B., Lattman E. E., Love W. E. (1975) Crystal structure of sickle-cell deoxyhemoglobin at 5 Å resolution. J. Mol. Biol. 98, 179–194 [DOI] [PubMed] [Google Scholar]
  • 9. Watowich S. J., Gross L. J., Josephs R. (1989) Intermolecular contacts within sickle hemoglobin fibers. J. Mol. Biol. 209, 821–828 [DOI] [PubMed] [Google Scholar]
  • 10. Padlan E. A., Love W. E. (1985) Refined crystal structure of deoxyhemoglobin S. II. Molecular interactions in the crystal. J. Biol. Chem. 260, 8280–8291 [PubMed] [Google Scholar]
  • 11. Harrington D. J., Adachi K., Royer W. E., Jr. (1997) The high resolution crystal structure of deoxyhemoglobin S. J. Mol. Biol. 272, 398–407 [DOI] [PubMed] [Google Scholar]
  • 12. Padlan E. A., Love W. E. (1985) Refined crystal structure of deoxyhemoglobin S. I. Restrained least-squares refinement at 3.0-Å resolution. J. Biol. Chem. 260, 8272–8279 [DOI] [PubMed] [Google Scholar]
  • 13. Adachi K., Kim J., Travitz R., Harano T., Asakura T. (1987) Effect of amino acid at the β6 position on surface hydrophobicity, stability, solubility, and the kinetics of polymerization of hemoglobin. Comparisons among Hb A (Glu β6), Hb C (Lys β6), Hb Machida (Gln β6), and Hb S (Val β6). J. Biol. Chem. 262, 12920–12925 [PubMed] [Google Scholar]
  • 14. Adachi K., Ding M., Asakura T., Surrey S. (2009) Relationship between β4 hydrogen bond and β6 hydrophobic interactions during aggregate, fiber or crystal formation in oversaturated solutions of hemoglobin A and S. Arch. Biochem. Biophys. 481, 137–144 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Adachi K., Ding M., Surrey S. (2008) Role of the β4Thr-β73Asp hydrogen bond in HbS polymer and domain formation from multinucleate-containing clusters. Biochemistry 47, 5441–5449 [DOI] [PubMed] [Google Scholar]
  • 16. Adachi K., Konitzer P., Paulraj C. G., Surrey S. (1994) Role of Leu-β88 in the hydrophobic acceptor pocket for Val-β6 during hemoglobin S polymerization. J. Biol. Chem. 269, 17477–17480 [PubMed] [Google Scholar]
  • 17. Adachi K., Konitzer P., Surrey S. (1994) Role of γ87 Gln in the inhibition of hemoglobin S polymerization by hemoglobin F. J. Biol. Chem. 269, 9562–9567 [PubMed] [Google Scholar]
  • 18. Adachi K., Reddy L. R., Surrey S. (1994) Role of hydrophobicity of phenylalanine β85 and leucine β88 in the acceptor pocket for valine β6 during hemoglobin S polymerization. J. Biol. Chem. 269, 31563–31566 [PubMed] [Google Scholar]
  • 19. Himanen J.-P., Popowicz A. M., Manning J. M. (1997) Recombinant sickle hemoglobin containing a lysine substitution at Asp-85(α): expression in yeast, functional properties, and participation in gel formation. Blood 89, 4196–4203 [PubMed] [Google Scholar]
  • 20. Himanen J.-P., Schneider K., Chait B., Manning J. M. (1995) Participation and strength of interaction of lysine 95(β) in the polymerization of hemoglobin S as determined by its site-directed substitution by isoleucine. J. Biol. Chem. 270, 13885–13891 [DOI] [PubMed] [Google Scholar]
  • 21. Sivaram M. V. S., Sudha R., Roy R. P. (2001) A role for the α113 (GH1) amino acid residue in the polymerization of sickle hemoglobin. Evaluation of its inhibitory strength and interaction linkage with two fiber contact sites (α16/23) located in the AB region of the α-chain. J. Biol. Chem. 276, 18209–18215 [DOI] [PubMed] [Google Scholar]
  • 22. Ho C., Willis B. F., Shen T. J., Dazhen N. T., Sun D. P., Tam M. F., Suzuka S. M., Fabry M. E., Nagel R. L. (1996) Roles of α114 and β87 amino acid residues in the polymerization of hemoglobin S: Implications for gene therapy. J. Mol. Biol. 263, 475–485 [DOI] [PubMed] [Google Scholar]
  • 23. Srinivasulu S., Perumalsamy K., Upadhya R., Manjula B. N., Feiring S., Alami R., Bouhassira E., Fabry M. E., Nagel R. L., Acharya A. S. (2006) Pair-wise interactions of polymerization inhibitory contact site mutations of hemoglobin-S. Protein J. 25, 503–516 [DOI] [PubMed] [Google Scholar]
  • 24. Banerjee S., Mirsamadi N., Anantharaman L., Sivaram M. V., Gupta R. B., Choudhury D., Roy R. P. (2007) Modification of axial fiber contact residues impact sickle hemoglobin polymerization by perturbing a network of coupled interactions. Protein J. 26, 445–455 [DOI] [PubMed] [Google Scholar]
  • 25. Looker D., Mathews A. J., Neway J. O., Stetler G. L. (1994) Expression of recombinant human hemoglobin in Escherichia coli. Methods Enzymol. 231, 364–374 [DOI] [PubMed] [Google Scholar]
  • 26. Shen T. J., Ho N. T., Simplaceanu V., Zou M., Green B. N., Tam M. F., Ho C. (1993) Production of unmodified human adult hemoglobin in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 90, 8108–8112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Lindstrom T. R., Ho C. (1972) Functional nonequivalence of α and β hemes in human adult hemoglobin. Proc. Natl. Acad. Sci. U.S.A. 69, 1707–1710 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Tam M. F., Chen J., Tam T. C. S., Tsai C. H., Shen T. J., Simplaceanu V., Feinstein T. N., Barrick D., Ho C. (2005) Enhanced inhibition of polymerization of sickle cell hemoglobin in the presence of recombinant mutants of human fetal hemoglobin with substitutions at position 43 in the γ-chain. Biochemistry 44, 12188–12195 [DOI] [PubMed] [Google Scholar]
  • 29. Hayashi A., Suzuki T., Shin M. (1973) An enzymic reduction system for metmyoglobin and methemoglobin, and its application to functional studies of oxygen carriers. Biochim. Biophys. Acta 310, 309–316 [DOI] [PubMed] [Google Scholar]
  • 30. Adachi K., Asakura T. (1979) Nucleation-controlled aggregation of deoxyhemoglobin S. Possible difference in the size of nuclei in different phosphate concentrations. J. Biol. Chem. 254, 7765–7771 [PubMed] [Google Scholar]
  • 31. Tam M. F., Rice N. W., Maillett D. H., Simplaceanu V., Ho N. T., Tam T. C., Shen T. J., Ho C. (2013) Autoxidation and oxygen binding properties of recombinant hemoglobins with substitutions at the αVal-62 or βVal-67 position of the distal heme pocket. J. Biol. Chem. 288, 25512–25521 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Plateau P., Gueron M. (1982) Exchangeable proton NMR without base-line distortion, using new strong-pulse sequences. J. Am. Chem. Soc. 104, 7310–7311 [Google Scholar]
  • 33. Dickerson R. E., Geis I. (1983) Hemoglobin: Structure, Function, Evolution, and Pathology, pp. 19–61, Benjamin/Cummings, Menlo Park, CA [Google Scholar]
  • 34. Wyman J., Jr. (1964) Linked functions and reciprocal effects in hemoglobin: a second look. Adv. Protein Chem. 19, 223–286 [DOI] [PubMed] [Google Scholar]
  • 35. Hofrichter J., Ross P. D., Eaton W. A. (1974) Kinetics and mechanism of deoxyhemoglobin S gelation: a new approach to understanding sickle cell disease. Proc. Natl. Acad. Sci. U.S.A. 71, 4864–4868 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Kowalczykowski S., Steinhardt J. (1977) Kinetics of hemoglobin S gelation followed by continuously sensitive low-shear viscosity. J. Mol. Biol. 115, 201–213 [DOI] [PubMed] [Google Scholar]
  • 37. Chang C. K., Simplaceanu V., Ho C. (2002) Effects of amino acid substitutions at β131 on the structure and properties of hemoglobin: evidence for communication between α1β1- and α1β2-subunit interfaces. Biochemistry 41, 5644–5655 [DOI] [PubMed] [Google Scholar]
  • 38. Russu I. M., Ho N. T., Ho C. (1987) A proton nuclear Overhauser effect investigation of the subunit interfaces in human normal adult hemoglobin. Biochim. Biophys. Acta 914, 40–48 [DOI] [PubMed] [Google Scholar]
  • 39. Simplaceanu V., Lukin J. A., Fang T. Y., Zou M., Ho N. T., Ho C. (2000) Chain-selective isotopic labeling for NMR studies of large multimeric proteins: application to hemoglobin. Biophys. J. 79, 1146–1154 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Fang T. Y., Simplaceanu V., Tsai C. H., Ho N. T., Ho C. (2000) An additional H-bond in the α1β2 interface as the structural basis for the low oxygen affinity and high cooperativity of a novel recombinant hemoglobin (βL105W). Biochemistry 39, 13708–13718 [DOI] [PubMed] [Google Scholar]
  • 41. Dalvit C., Ho C. (1985) Proton nuclear Overhauser effect investigation of the heme pockets in ligated hemoglobin: conformational differences between oxy and carbonmonoxy forms. Biochemistry 24, 3398–3407 [DOI] [PubMed] [Google Scholar]
  • 42. Lindstrom T. R., Norén I. B. E., Charache S., Lehmann H., Ho C. (1972) Nuclear magnetic resonance studies of hemoglobins. VII. Tertiary structure around ligand binding site in carbonmonoxyhemoglobin. Biochemistry 11, 1677–1681 [DOI] [PubMed] [Google Scholar]
  • 43. La Mar G. N., Nagai K., Jue T., Budd D. L., Gersonde K., Sick H., Kagimoto T., Hayashi A., Taketa F. (1980) Assignment of proximal histidyl imidazole exchangeable proton NMR resonances to individual subunits in hemoglobins A, Boston, Iwate and Milwaukee. Biochem. Biophys. Res. Commun. 96, 1172–1177 [DOI] [PubMed] [Google Scholar]
  • 44. Takahashi S., Lin A. K., Ho C. (1980) Proton nuclear magnetic-resonance studies of hemoglobin-M-Boston (α58E7 His → Tyr) and Hemoglobin-M-Milwaukee (β67E11 Val → Glu): spectral assignments of hyperfine-shifted proton resonances and of proximal histidine (E7) NH resonances to the α-chains and β-chains of normal human adult hemoglobin. Biochemistry 19, 5196–5202 [DOI] [PubMed] [Google Scholar]
  • 45. Ho C. (1992) Proton nuclear-magnetic-resonance studies on hemoglobin: cooperative interactions and partially ligated intermediates. Adv. Protein Chem. 43, 153–312 [DOI] [PubMed] [Google Scholar]
  • 46. Fung L. W. M., Ho C. (1975) Proton nuclear magnetic-resonance study of quaternary structure of human hemoglobins in water. Biochemistry 14, 2526–2535 [DOI] [PubMed] [Google Scholar]
  • 47. Ishimori K., Imai K., Miyazaki G., Kitagawa T., Wada Y., Morimoto H., Morishima I. (1992) Site-directed mutagenesis in hemoglobin: functional and structural role of inter- and intrasubunit hydrogen bonds as studied with 37β and 145β mutations. Biochemistry 31, 3256–3264 [DOI] [PubMed] [Google Scholar]
  • 48. Perutz M. F., Mitchison J. M. (1950) State of haemoglobin in sickle-cell anaemia. Nature 166, 677–679 [DOI] [PubMed] [Google Scholar]
  • 49. Baudin-Chich V., Pagnier J., Marden M., Bohn B., Lacaze N., Kister J., Schaad O., Edelstein S. J., Poyart C. (1990) Enhanced polymerization of recombinant human deoxyhemoglobin β6 Glu → Ile. Proc. Natl. Acad. Sci. U.S.A. 87, 1845–1849 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Patskovska L. N., Patskovsky Y. V., Almo S. C., Hirsch R. E. (2005) COHbC and COHbS crystallize in the R2 quaternary state at neutral pH in the presence of PEG 4000. Acta Crystallogr. D Biol. Crystallogr. 61, 566–573 [DOI] [PubMed] [Google Scholar]
  • 51. Wellems T. E., Vassar R. J., Josephs R. (1981) Polymorphic assemblies of double strands of sickle cell hemoglobin. Manifold pathways of deoxyhemoglobin S crystallization. J. Mol. Biol. 153, 1011–1026 [DOI] [PubMed] [Google Scholar]
  • 52. Russu I. M., Ho C. (1980) Proton longitudinal relaxation investigation of histidyl residues of normal human adult and sickle deoxyhemoglobin: evidence for the existence of pre-gelation aggregates in sickle deoxyhemoglobin solutions. Proc. Natl. Acad. Sci. U.S.A. 77, 6577–6581 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Nagel R. L., Bookchin R. M., Johnson J., Labie D., Wajcman H., Isaac-Sodeye W. A., Honig G. R., Schilirò G., Crookston J. H., Matsutomo K. (1979) Structural bases of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S. Proc. Natl. Acad. Sci. U.S.A. 76, 670–672 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Acharya A. S., Seetharam R. (1985) Reactivity of Glu-22(β) of hemoglobin S for amidation with glucosamine. Biochemistry 24, 4885–4890 [DOI] [PubMed] [Google Scholar]
  • 55. Rhoda M. D., Blouquit Y., Caburi-Martin J., Monplaisir N., Galacteros F., Garel M. C., Rosa J. (1984) Effects of the α20 mutation on the polymerization of Hb S. Biochim. Biophys. Acta 786, 62–66 [DOI] [PubMed] [Google Scholar]
  • 56. Bookchin R. M., Balazs T., Wang Z., Josephs R., Lew V. L. (1999) Polymer structure and solubility of deoxyhemoglobin S in the presence of high concentrations of volume-excluding 70-kDa dextran: effect of non-S hemoglobins and inhibitors. J. Biol. Chem. 274, 6689–6697 [DOI] [PubMed] [Google Scholar]
  • 57. Yuan Y., Tam M. F., Simplaceanu V., Ho C. (2015) New look at hemoglobin allostery. Chem. Rev. 115, 1702–1724 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Adachi K., Pang J., Reddy L. R., Bradley L. E., Chen Q., Trifillis P., Schwartz E., Surrey S. (1996) Polymerization of three hemoglobin A2 variants containing Valδ6 and inhibition of hemoglobin S polymerization by hemoglobin A2. J. Biol. Chem. 271, 24557–24563 [DOI] [PubMed] [Google Scholar]
  • 59. Adachi K., Konitzer P., Kim J., Welch N., Surrey S. (1993) Effects of β6 aromatic amino acids on polymerization and solubility of recombinant hemoglobins made in yeast. J. Biol. Chem. 268, 21650–21656 [PubMed] [Google Scholar]
  • 60. Cao Z., Liao D., Mirchev R., Martin de Llano J. J., Himanen J. P., Manning J. M., Ferrone F. A. (1997) Nucleation and polymerization of sickle hemoglobin with Leu β88 substituted by Ala. J. Mol. Biol. 265, 580–589 [DOI] [PubMed] [Google Scholar]
  • 61. Reddy L. R., Reddy K. S., Surrey S., Adachi K. (1996) Role of hydrophobic amino acids at β85 and β88 in stabilizing F helix conformation of hemoglobin S. J. Biol. Chem. 271, 24564–24568 [DOI] [PubMed] [Google Scholar]
  • 62. McCune S. L., Reilly M. P., Chomo M. J., Asakura T., Townes T. M. (1994) Recombinant human hemoglobins designed for gene therapy of sickle cell disease. Proc. Natl. Acad. Sci. U.S.A. 91, 9852–9856 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Srinivasulu S., Acharya A. S., Prabhakaran M., Fabry M. E., Alami R., Fiering S. N., Bouhasirra E. E., Nagel R. L. (2007) HbS-Savaria: the anti-polymerization effect of a single mutation in human α-chains. Protein J. 26, 523–532 [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES